Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury

被引:97
作者
Khalin, Igor [1 ]
Alyautdin, Renad [2 ]
Wong, Tin Wui [3 ]
Gnanou, Justin [1 ]
Kocherga, Ganna [4 ]
Kreuter, Joerg [5 ]
机构
[1] Natl Def Univ Malaysia, Fac Med & Def Hlth, Kuala Lumpur, Malaysia
[2] Sci Ctr Expertise Med Applicat Prod, Moscow, Russia
[3] Univ Teknol MARA, Nondestruct Biomed & Pharmaceut Res Ctr, iPROMISE, Selangor, Malaysia
[4] Int Med Ctr Oftalm, Ophthalm Microsurg Dept, Kharkov, Ukraine
[5] Goethe Univ, Inst Pharmaceut Technol, Frankfurt, Germany
关键词
Blood-brain barrier; brain-derived neurotrophic factor; drug-delivery; nanoparticles; traumatic brain injury; POLY(BUTYL CYANOACRYLATE) NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN; FUNCTIONAL RECOVERY; BODY DISTRIBUTION; DRUG-DELIVERY; ANIMAL-MODELS; FACTOR BDNF; RAT; CELLS;
D O I
10.1080/10717544.2016.1199609
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Currently, traumatic brain injury (TBI) is the leading cause of death or disabilities in young individuals worldwide. The multi-complexity of its pathogenesis as well as impermeability of the blood-brain barrier (BBB) makes the drug choice and delivery very challenging. The brain-derived neurotrophic factor (BDNF) regulates neuronal plasticity, neuronal cell growth, proliferation, cell survival and long-term memory. However, its short half-life and low BBB permeability are the main hurdles to be an effective therapeutic for TBI. Poly (lactic-co-glycolic acid) (PLGA) nanoparticles coated by surfactant can enable the delivery of a variety of molecules across the BBB by receptor-mediated transcytosis. This study examines the ability of PLGA nanoparticles coated with poloxamer 188 (PX) to deliver BDNF into the brain and neuroprotective effects of BNDF in mice with TBI. C57bl/6 mice were subjected to weight-drop closed head injuries under anesthesia. Using enzyme-linked immunosorbent assay, we demonstrated that the intravenous (IV) injection of nanoparticle-bound BDNF coated by PX (NP-BDNF-PX) significantly increased BDNF levels in the brain of sham-operated mice (p<0.001) and in both ipsi-(p<0.001) and contralateral (p<0.001) parts of brain in TBI mice compared to controls. This study also showed using the passive avoidance (PA) test, that IV injection of NP-BDNF-PX 3h post-injury prolonged the latent time in mice with TBI thereby reversing cognitive deficits caused by brain trauma. Finally, neurological severity score test demonstrated that our compound efficiently reduced the scores at day 7 after the injury indicating the improvement of neurological deficit in animals with TBI. This study shows that PLGA nanoparticles coated with PX effectively delivered BDNF into the brain, and improved neurological and cognitive deficits in TBI mice, thereby providing a neuroprotective effect.
引用
收藏
页码:3520 / 3528
页数:9
相关论文
共 67 条
[1]
GDNF, NGF and BDNF as therapeutic options for neurodegeneration [J].
Allen, Shelley J. ;
Watson, Judy J. ;
Shoemark, Deborah K. ;
Barua, Neil U. ;
Patel, Nikunj K. .
PHARMACOLOGY & THERAPEUTICS, 2013, 138 (02) :155-175
[2]
Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J].
Alyautdin, RN ;
Petrov, VE ;
Langer, K ;
Berthold, A ;
Kharkevich, DA ;
Kreuter, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (03) :325-328
[3]
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study [J].
Alyautdin, RN ;
Tezikov, EB ;
Ramge, P ;
Kharkevich, DA ;
Begley, DJ ;
Kreuter, J .
JOURNAL OF MICROENCAPSULATION, 1998, 15 (01) :67-74
[4]
DIFFERENTIAL DISTRIBUTION OF EXOGENOUS BDNF, NGF, AND NT-3 IN THE BRAIN CORRESPONDS TO THE RELATIVE ABUNDANCE AND DISTRIBUTION OF HIGH-AFFINITY AND LOW-AFFINITY NEUROTROPHIN RECEPTORS [J].
ANDERSON, KD ;
ALDERSON, RF ;
ALTAR, CA ;
DISTEFANO, PS ;
CORCORAN, TL ;
LINDSAY, RM ;
WIEGAND, SJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 357 (02) :296-317
[5]
Baskaya MK, 1997, NEUROSCI LETT, V226, P33
[6]
BDNF AND NT-3 INDUCE INTRACELLULAR CA2+ ELEVATION IN HIPPOCAMPAL-NEURONS [J].
BERNINGER, B ;
GARCIA, DE ;
INAGAKI, N ;
HAHNEL, C ;
LINDHOLM, D .
NEUROREPORT, 1993, 4 (12) :1303-1306
[7]
Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits [J].
Blaha, GR ;
Raghupathi, R ;
Saatman, KE ;
Mcintosh, TK .
NEUROSCIENCE, 2000, 99 (03) :483-493
[8]
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease [J].
Blurton-Jones, Mathew ;
Kitazawa, Masashi ;
Martinez-Coria, Hilda ;
Castello, Nicholas A. ;
Mueller, Franz-Josef ;
Loring, Jeanne F. ;
Yamasaki, Tritia R. ;
Poon, Wayne W. ;
Green, Kim N. ;
LaFerla, Frank M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (32) :13594-13599
[9]
Guidelines for the Management of Severe Traumatic Brain Injury: Editor's commentary [J].
Bullock, M. Ross ;
Povlishock, John T. .
JOURNAL OF NEUROTRAUMA, 2007, 24 :VII-VIII
[10]
Neural Stem Cells Modified to Express BDNF Antagonize Trimethyltin-Induced Neurotoxicity Through PI3K/Akt and MAP Kinase Pathways [J].
Casalbore, Patrizia ;
Barone, Ilaria ;
Felsani, Armando ;
D'Agnano, Igea ;
Michetti, Fabrizio ;
Maira, Giulio ;
Cenciarelli, Carlo .
JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 224 (03) :710-721